Live feed
Filing
SCHEDULE 13G
SCHEDULE 13G0001104659-25-015192·EAGLE PHARMACEUTICALS, INC.
Schedule 13G ownership disclosure
EAGLE PHARMACEUTICALS INC
Common Stock, par value $0.001 per share · CUSIP: 269796108
Event date: 2025-02-16
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- NANTAHALA CAPITAL PARTNERS LIMITED PARTNERSHIP
Shares: 810,630.00 · Class: 6.241%
- Wilmot B. Harkey
Shares: 810,630.00 · Class: 6.241%
- Daniel Mack
Shares: 810,630.00 · Class: 6.241%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001104659-25-015192
- Form type
- SCHEDULE 13G
- Filer
- EAGLE PHARMACEUTICALS, INC.
- CIK
- CIK 827871
- Filed
- Feb 19, 2025
- Reporting period
- Feb 16, 2025
- Description
- Schedule 13G beneficial ownership